In recent years, GLUT-1 was also reported to be overexpressed in various cancer types including hepatocellular carcinoma [10], prostate carcinoma [11], lung adenocarcinoma [12], oral squamous cell carcinoma [13], and pancreatic cancer [14–16]. Here, SLC2A1 is linked to pancreatic neoplasm.